Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer
Tuesday, July 21, 2026
5:15 PM - 6:15 PM CT
This program brings together expert faculty to discuss the latest advances and enable the integration of oral SERDs and emerging combination strategies into HR+/HER2- metastatic breast cancer care.
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer
Tuesday, September 15, 2026
5:15 PM - 6:15 PM CT
This online, CME-certified Oncology State Societies at ACCC Meeting Series – How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer, will bring together expert faculty to review the key recent findings and discuss their potential implications for community oncologists.